{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:17:07Z","timestamp":1792289827429,"version":"4.4.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1053\/j.semdp.2022.06.001","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T19:18:44Z","timestamp":1654975124000},"page":"344-354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Papillary lesions of the breast \u2013 review and practical issues"],"prefix":"10.1053","volume":"39","author":[{"given":"Yunbi","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary M","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2022.06.001_bib0001","unstructured":"WHO Classification of Tumours Editorial Board. Breast Tumours. WHO Classification of Tumours, 5th Edition, Volume 2. Vol 2. 5th Edition. Lyon, France: IARC; 2019. Introduction in Papillary neoplasms."},{"issue":"1","key":"10.1053\/j.semdp.2022.06.001_bib0002","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pathol.2017.10.005","article-title":"Diagnostic challenges in papillary lesions of the breast","volume":"50","author":"Rakha","year":"2018","journal-title":"Pathology"},{"issue":"1","key":"10.1053\/j.semdp.2022.06.001_bib0003","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2559.2007.02898.x","article-title":"Papillary lesions of the breast: selected diagnostic and management issues","volume":"52","author":"Collins","year":"2008","journal-title":"Histopathology"},{"issue":"1","key":"10.1053\/j.semdp.2022.06.001_bib0004","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/his.12866","article-title":"Pathological criteria and practical issues in papillary lesions of the breast - a review","volume":"68","author":"Ni","year":"2016","journal-title":"Histopathology"},{"issue":"10","key":"10.1053\/j.semdp.2022.06.001_bib0005","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.5858\/arpa.2016-0219-RA","article-title":"Papillary lesions of the breast: a practical approach to diagnosis","volume":"140","author":"Jorns","year":"2016","journal-title":"Arch Pathol Lab Med"},{"issue":"7","key":"10.1053\/j.semdp.2022.06.001_bib0006","doi-asserted-by":"crossref","first-page":"628","DOI":"10.5858\/arpa.2015-0092-RA","article-title":"Papillary lesions of the breast: an update","volume":"140","author":"Wei","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2022.06.001_bib0007","article-title":"Papillary breast tumors: continuing controversies and commentary on WHO's 2019 criteria and classification","author":"Patel","year":"2021","journal-title":"Int J Surg Pathol"},{"key":"10.1053\/j.semdp.2022.06.001_bib0008","article-title":"Papillary lesions of the breast","author":"Kulka","year":"2021","journal-title":"Virchows Arch"},{"issue":"8","key":"10.1053\/j.semdp.2022.06.001_bib0009","doi-asserted-by":"crossref","first-page":"770","DOI":"10.5858\/arpa.2015-0525-RA","article-title":"Practical considerations in breast papillary lesions: a review of the literature","volume":"140","author":"Agoumi","year":"2016","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1053\/j.semdp.2022.06.001_bib0010","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41379-020-00706-5","article-title":"Papillary neoplasms of the breast including upgrade rates and management of intraductal papilloma without atypia diagnosed at core needle biopsy","volume":"34","author":"Brogi","year":"2021","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2022.06.001_bib0011","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41379-020-00732-3","article-title":"Papillary neoplasms of the breast-reviewing the spectrum","volume":"34","author":"Tay","year":"2021","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2022.06.001_bib0012","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00000478-200606000-00001","article-title":"An analysis of breast cancer risk in women with single, multiple, and atypical papilloma","volume":"30","author":"Lewis","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2022.06.001_bib0013","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0046-8177(84)80168-9","article-title":"Infarction and squamous metaplasia of intraductal papilloma: a benign breast lesion that may simulate carcinoma","volume":"15","author":"Flint","year":"1984","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2022.06.001_bib0014","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s004280000366","article-title":"Sebaceous gland metaplasia in intraductal papilloma of the breast","volume":"438","author":"Jiao","year":"2001","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1053\/j.semdp.2022.06.001_bib0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/jclinpath-2013-201749","article-title":"Broad fibrovascular cores may not be an exclusively benign feature in papillary lesions of the breast: a cautionary note","volume":"67","author":"Yamaguchi","year":"2014","journal-title":"J Clin Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2022.06.001_bib0016","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/(SICI)1097-0142(19960715)78:2<258::AID-CNCR11>3.0.CO;2-V","article-title":"Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma","volume":"78","author":"Page","year":"1996","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2022.06.001_bib0017","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13000-014-0227-3","article-title":"Ductal carcinoma in situ of the breast: correlation between histopathological features and age of patients","volume":"9","author":"Perez","year":"2014","journal-title":"Diagn Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2022.06.001_bib0018","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/0046-8177(94)90250-X","article-title":"Intraductal (intracystic) papillary carcinoma of the breast and its variants: a clinicopathological study of 77 cases","volume":"25","author":"Lefkowitz","year":"1994","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2022.06.001_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0b013e3181fbe20a","article-title":"Intracystic papillary carcinoma of the breast: an in situ or invasive tumor? Results of immunohistochemical analysis and clinical follow-up","volume":"35","author":"Wynveen","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2022.06.001_bib0020","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/PAS.0b013e31821b3f65","article-title":"Encapsulated papillary carcinoma of the breast: an invasive tumor with excellent prognosis","volume":"35","author":"Rakha","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2022.06.001_bib0021","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1309\/AJCP8A2UVLCYGTPU","article-title":"Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases","volume":"131","author":"Esposito","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2022.06.001_bib0022","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/path.3032","article-title":"Immunophenotypic and genomic characterization of papillary carcinomas of the breast","volume":"226","author":"Duprez","year":"2012","journal-title":"J Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2022.06.001_bib0023","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/his.12591","article-title":"High-grade encapsulated papillary carcinoma of the breast: an under-recognized entity","volume":"66","author":"Rakha","year":"2015","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2022.06.001_bib0024","unstructured":"WHO Classification of Tumours Editorial Board. Breast Tumours. WHO Classification of Tumours, 5th Edition, Volume 2. Vol 2. 5th Edition. Lyon, France: IARC; 2019. Solid papillary carcinoma (in situ and invasive) in Papillary neoplasms."},{"issue":"10","key":"10.1053\/j.semdp.2022.06.001_bib0025","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1097\/PAS.0000000000000702","article-title":"Clinicopathologic characteristics of solid papillary carcinoma of the breast","volume":"40","author":"Tan","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2022.06.001_bib0026","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/ajcp\/73.3.313","article-title":"Pathologic findings from the national surgical adjuvant breast project (protocol no. 4). VI. Invasive papillary cancer","volume":"73","author":"Fisher","year":"1980","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2022.06.001_bib0027","first-page":"e13480","article-title":"Invasive papillary carcinoma of the breast: clinicopathological features and hormone receptor profile","volume":"13","author":"Hashmi","year":"2021","journal-title":"Cureus"},{"issue":"2","key":"10.1053\/j.semdp.2022.06.001_bib0028","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10549-015-3413-4","article-title":"Invasive micropapillary mucinous carcinoma of the breast is associated with poor prognosis","volume":"151","author":"Liu","year":"2015","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1053\/j.semdp.2022.06.001_bib0029","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1186\/s12885-017-3855-7","article-title":"The prognosis of invasive micropapillary carcinoma compared with invasive ductal carcinoma in the breast: a meta-analysis","volume":"17","author":"Wu","year":"2017","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1053\/j.semdp.2022.06.001_bib0030","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/ajcp\/aqx016","article-title":"Breast tumor resembling tall cell variant of papillary thyroid carcinoma: a solid papillary neoplasm with characteristic immunohistochemical profile and few recurrent mutations","volume":"147","author":"Bhargava","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2022.06.001_bib0031","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/00000478-200308000-00008","article-title":"Breast tumor resembling the tall cell variant of papillary thyroid carcinoma: report of 5 cases","volume":"27","author":"Eusebi","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2022.06.001_bib0032","doi-asserted-by":"crossref","first-page":"837","DOI":"10.21037\/gs-20-695","article-title":"Tall cell carcinoma of the breast with reverse polarity: case report with gene sequencing and literature review","volume":"10","author":"Zhang","year":"2021","journal-title":"Gland Surg"},{"key":"10.1053\/j.semdp.2022.06.001_bib0033","unstructured":"WHO Classification of Tumours Editorial Board. Breast Tumours. WHO Classification of Tumours, 5th Edition, Volume 2. Vol 2. 5th Edition. Lyon, France: IARC; 2019. Tall cell carcinoma with reversed polarity in Rare and salivary gland-type tumours."},{"issue":"24","key":"10.1053\/j.semdp.2022.06.001_bib0034","doi-asserted-by":"crossref","first-page":"7118","DOI":"10.1158\/0008-5472.CAN-16-0298","article-title":"IDH2 mutations define a unique subtype of breast cancer with altered nuclear polarity","volume":"76","author":"Chiang","year":"2016","journal-title":"Cancer Res"},{"issue":"7","key":"10.1053\/j.semdp.2022.06.001_bib0035","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/PAS.0000000000000853","article-title":"Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms: a unique invasive tumor with indolent behavior","volume":"41","author":"Foschini","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2022.06.001_bib0036","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/jcp.2006.036830","article-title":"The role of immunohistochemistry for smooth-muscle actin, p63, CD10 and cytokeratin 14 in the differential diagnosis of papillary lesions of the breast","volume":"60","author":"Tse","year":"2007","journal-title":"J Clin Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2022.06.001_bib0037","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/01.pas.0000157941.88161.39","article-title":"Cytokeratins in papillary lesions of the breast: is there a role in distinguishing intraductal papilloma from papillary ductal carcinoma in situ?","volume":"29","author":"Tan","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2022.06.001_bib0038","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/jcp.2008.063016","article-title":"The role of immunohistochemistry in the differential diagnosis of papillary lesions of the breast","volume":"62","author":"Tse","year":"2009","journal-title":"J Clin Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2022.06.001_bib0039","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/his.12453","article-title":"Immunohistochemistry in the diagnosis of papillary lesions of the breast","volume":"65","author":"Tse","year":"2014","journal-title":"Histopathology"},{"issue":"3","key":"10.1053\/j.semdp.2022.06.001_bib0040","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12253-014-9882-7","article-title":"Non-malignant breast papillary lesions - b3 diagnosed on ultrasound\u2013guided 14-gauge needle core biopsy: analysis of 114 cases from a single institution and review of the literature","volume":"21","author":"Bianchi","year":"2015","journal-title":"Pathol Oncol Res"},{"issue":"4","key":"10.1053\/j.semdp.2022.06.001_bib0041","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/his.12477","article-title":"Management of breast papillary lesions diagnosed in ultrasound-guided vacuum-assisted and core needle biopsies","volume":"66","author":"Yamaguchi","year":"2015","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2022.06.001_bib0042","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1746-1596-9-86","article-title":"Follow-up of breast papillary lesion on core needle biopsy: experience in African-American population","volume":"9","author":"Wang","year":"2014","journal-title":"Diagn Pathol"},{"issue":"12","key":"10.1053\/j.semdp.2022.06.001_bib0043","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1177\/000313481307901212","article-title":"Papillary lesions on core breast biopsy: excisional biopsy for all patients?","volume":"79","author":"McGhan","year":"2013","journal-title":"Am Surg"},{"issue":"2","key":"10.1053\/j.semdp.2022.06.001_bib0044","first-page":"51","article-title":"Histological evaluation of papillary lesions of the breast from needle biopsy to the excised specimen: a single institutional experience","volume":"105","author":"Gilani","year":"2013","journal-title":"Pathologica"},{"issue":"13","key":"10.1053\/j.semdp.2022.06.001_bib0045","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1245\/s10434-013-3191-3","article-title":"Management of papillary lesions of the breast: can larger core needle biopsy samples identify patients who may avoid surgical excision?","volume":"20","author":"Shamonki","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1053\/j.semdp.2022.06.001_bib0046","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10549-012-2403-z","article-title":"Can additional immunohistochemistry staining replace the surgical excision for the diagnosis of papillary breast lesions classified as benign on 14-gage core needle biopsy?","volume":"137","author":"Koo","year":"2013","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1053\/j.semdp.2022.06.001_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcu.21993","article-title":"Accuracy of percutaneous core needle biopsy in diagnosing papillary breast lesions and potential impact of sonographic features on their management","volume":"41","author":"Al Hassan","year":"2013","journal-title":"J Clin Ultrasound"},{"issue":"6","key":"10.1053\/j.semdp.2022.06.001_bib0048","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3892\/etm.2011.332","article-title":"Papillary lesions of the breast diagnosed using core needle biopsies","volume":"2","author":"Tokiniwa","year":"2011","journal-title":"Exp Ther Med"},{"issue":"11","key":"10.1053\/j.semdp.2022.06.001_bib0049","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.ejso.2012.08.019","article-title":"Papillary breast lesions diagnosed by core biopsy require complete excision","volume":"38","author":"Fu","year":"2012","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1053\/j.semdp.2022.06.001_bib0050","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1148\/radiol.12111926","article-title":"Pathologic outcomes of nonmalignant papillary breast lesions diagnosed at imaging-guided core needle biopsy","volume":"265","author":"Holley","year":"2012","journal-title":"Radiology"},{"issue":"4","key":"10.1053\/j.semdp.2022.06.001_bib0051","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/PAS.0b013e318243fa00","article-title":"Papillary lesions of the breast: impact of breast pathology subspecialization on core biopsy and excision diagnoses","volume":"36","author":"Jakate","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2022.06.001_bib0052","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1245\/s10434-012-2590-1","article-title":"Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors","volume":"20","author":"Wen","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1053\/j.semdp.2022.06.001_bib0053","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1245\/s10434-020-09215-w","article-title":"The incidence of adjacent synchronous invasive carcinoma and\/or Ductal Carcinoma In situ in patients with intraductal papilloma without atypia on core biopsy: results from a prospective multi-institutional registry (TBCRC 034)","volume":"28","author":"Nakhlis","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1053\/j.semdp.2022.06.001_bib0054","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-018-05071-1","article-title":"Second International consensus conference on lesions of uncertain malignant potential in the breast (B3 lesions)","volume":"174","author":"Rageth","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1053\/j.semdp.2022.06.001_bib0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/j.semdp.2009.12.004","article-title":"Papilloma and papillary carcinoma","volume":"27","author":"Koerner","year":"2010","journal-title":"Semin Diagn Pathol"},{"issue":"11","key":"10.1053\/j.semdp.2022.06.001_bib0056","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.5858\/2005-129-1465-EDIBLA","article-title":"Epithelial displacement in breast lesions: a papillary phenomenon","volume":"129","author":"Nagi","year":"2005","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"10.1053\/j.semdp.2022.06.001_bib0057","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/jcp.55.10.780","article-title":"Diagnostic difficulty arising from displaced epithelium after core biopsy in intracystic papillary lesions of the breast","volume":"55","author":"Douglas-Jones","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.semdp.2022.06.001_bib0058","unstructured":"Ellis I.O., Carder P., Hales S., Lee A.H.S., Pinder S.E., Rakha, E., et\u00a0al. Pathology reporting of breast disease in surgical excision specimens incorporating the dataset for histological reporting of breast cancer. 2016. https:\/\/www.rcpath.org\/uploads\/assets\/7763be1c-d330-40e8-95d08f955752792a\/G148_BreastDataset-hires-Jun16.pdf."},{"issue":"8","key":"10.1053\/j.semdp.2022.06.001_bib0059","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/00000478-200608000-00011","article-title":"Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers","volume":"30","author":"Collins","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1053\/j.semdp.2022.06.001_bib0060","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/path.3032","article-title":"Immunophenotypic and genomic characterization of papillary carcinomas of the breast","volume":"226","author":"Duprez","year":"2012","journal-title":"J Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2022.06.001_bib0061","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/modpathol.2013.136","article-title":"Intracystic papillary carcinoma of breast: interrelationship with in situ and invasive carcinoma and a proposal of pathogenesis: array comparative genomic hybridization study of 14 cases","volume":"27","author":"Khoury","year":"2014","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1053\/j.semdp.2022.06.001_bib0062","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/jclinpath-2012-200710","article-title":"Encapsulated papillary carcinoma of the breast: a study of invasion associated markers","volume":"65","author":"Rakha","year":"2012","journal-title":"J Clin Pathol"},{"issue":"6","key":"10.1053\/j.semdp.2022.06.001_bib0063","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.amjsurg.2006.01.019","article-title":"Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer","volume":"191","author":"Katz","year":"2006","journal-title":"Am J Surg"},{"issue":"4","key":"10.1053\/j.semdp.2022.06.001_bib0064","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00000478-200604000-00011","article-title":"Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas","volume":"30","author":"Nassar","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2022.06.001_bib0065","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.breast.2015.12.015","article-title":"Solid papillary carcinoma of the breast: a special entity needs to be distinguished from conventional invasive carcinoma avoiding over-treatment","volume":"26","author":"Guo","year":"2016","journal-title":"Breast"},{"issue":"7","key":"10.1053\/j.semdp.2022.06.001_bib0066","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1440-1827.2007.02118.x","article-title":"Solid-papillary carcinoma of the breast: clinicopathological study of 20 cases","volume":"57","author":"Otsuki","year":"2007","journal-title":"Pathol Int"},{"issue":"5","key":"10.1053\/j.semdp.2022.06.001_bib0067","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2559.2007.02849.x","article-title":"Loss of myoepithelium is variable in solid papillary carcinoma of the breast","volume":"51","author":"Nicolas","year":"2007","journal-title":"Histopathology"},{"issue":"8","key":"10.1053\/j.semdp.2022.06.001_bib0068","doi-asserted-by":"crossref","first-page":"979","DOI":"10.5858\/arpa.2020-0288-OA","article-title":"HER2 immunohistochemistry in invasive micropapillary breast Carcinoma: complete assessment of an incomplete pattern","volume":"145","author":"Perron","year":"2021","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1053\/j.semdp.2022.06.001_bib0069","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/his.12147","article-title":"The clinical relevance of micropapillary carcinoma of the breast: a case-control study","volume":"63","author":"Vingiani","year":"2013","journal-title":"Histopathology"},{"issue":"11","key":"10.1053\/j.semdp.2022.06.001_bib0070","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1038\/modpathol.2017.65","article-title":"Downs-Kelly E. HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features","volume":"30","author":"Stewart","year":"2017","journal-title":"Mod Pathol"},{"issue":"20","key":"10.1053\/j.semdp.2022.06.001_bib0071","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American society of clinical oncology\/college of American pathologists clinical practice guideline focused update","volume":"36","author":"Wolff","year":"2018","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1053\/j.semdp.2022.06.001_bib0072","first-page":"1320","article-title":"Clonal analysis of solitary intraductal papilloma of the breast by means of polymerase chain reaction","volume":"144","author":"Noguchi","year":"1994","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1053\/j.semdp.2022.06.001_bib0073","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ajpath.2018.01.005","article-title":"Mutational analysis of AKT1 and PIK3CA in intraductal papillomas of the breast with special reference to cellular components","volume":"188","author":"Mishima","year":"2018","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2022.06.001_bib0074","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/modpathol.2009.142","article-title":"High prevalence of PIK3CA\/AKT pathway mutations in papillary neoplasms of the breast","volume":"23","author":"Troxell","year":"2010","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1053\/j.semdp.2022.06.001_bib0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ajpath.2015.09.004","article-title":"Mutation profiling of usual ductal hyperplasia of the breast reveals activating mutations predominantly at different levels of the PI3K\/AKT\/mTOR pathway","volume":"186","author":"Jahn","year":"2016","journal-title":"Am J Pathol"},{"issue":"10","key":"10.1053\/j.semdp.2022.06.001_bib0076","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0046-8177(98)90422-1","article-title":"LOH at 16p13 is a novel chromosomal alteration detected in benign and malignant microdissected papillary neoplasms of the breast","volume":"29","author":"Lininger","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2022.06.001_bib0077","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41523-020-0150-6","article-title":"The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma","volume":"6","author":"Kader","year":"2020","journal-title":"NPJ Breast Cancer"},{"issue":"8","key":"10.1053\/j.semdp.2022.06.001_bib0078","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.molonc.2014.06.011","article-title":"Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast","volume":"8","author":"Piscuoglio","year":"2014","journal-title":"Mol Oncol"},{"issue":"3","key":"10.1053\/j.semdp.2022.06.001_bib0079","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/path.3032","article-title":"Immunophenotypic and genomic characterization of papillary carcinomas of the breast","volume":"226","author":"Duprez","year":"2012","journal-title":"J Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2022.06.001_bib0080","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/modpathol.2013.136","article-title":"Intracystic papillary carcinoma of breast: interrelationship with in situ and invasive carcinoma and a proposal of pathogenesis: array comparative genomic hybridization study of 14 cases","volume":"27","author":"Khoury","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2022.06.001_bib0081","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.humpath.2021.02.005","article-title":"Molecular analysis of encapsulated papillary carcinoma of the breast with and without invasion","volume":"111","author":"Schwartz","year":"2021","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2022.06.001_bib0082","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/1066896918800779","article-title":"Breast tumor resembling the tall cell variant of papillary thyroid carcinoma: molecular characterization by next-generation sequencing and histopathological comparison with tall cell papillary carcinoma of thyroid","volume":"27","author":"Zhong","year":"2019","journal-title":"Int J Surg Pathol"},{"issue":"9","key":"10.1053\/j.semdp.2022.06.001_bib0083","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/s41379-018-0047-1","article-title":"Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional cases","volume":"31","author":"Alsadoun","year":"2018","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1053\/j.semdp.2022.06.001_bib0084","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/his.13522","article-title":"Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting IDH2 and PIK3CA: a validation cohort","volume":"73","author":"Lozada","year":"2018","journal-title":"Histopathology"},{"issue":"6","key":"10.1053\/j.semdp.2022.06.001_bib0085","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1007\/s11033-020-05553-w","article-title":"Tall cell carcinoma of the breast with reversed polarity (TCCRP) with mutations in the IDH2 and PIK3CA genes: a case report","volume":"47","author":"Haefliger","year":"2020","journal-title":"Mol Biol Rep"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257022000405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257022000405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:23:26Z","timestamp":1760037806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257022000405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0740257022000405"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2022.06.001","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Papillary lesions of the breast \u2013 review and practical issues","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2022.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}